Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Phosphorylation of PFK2 is decreased in cardiomyocytes cultured in the absence of insulin and with diabetes. by Craig A. Eyster (9262632)

“…Scale bar 10μm. (B) Quantitation of mean fluorescence intensity (MFI) for pPFK2 are presented as whisker plots that encompass data from at least 18 cells, as detailed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231806#pone.0231806.g001" target="_blank">Fig 1</a> (n = 3 biological replicates, and at least 6 cells per experiment). (*) IBMX or Isoproterenol treatment causes a significant increase (<i>p</i> < .001) compared to untreated WT cells; (†) Each WT (-ins) condition is significantly decreased (<i>p</i> < .001) compared to WT (+ins); (‡) all Akita conditions are significantly decreased (<i>p</i> < .001) compared to comparable WT conditions. …”

PKA signaling stimulated by the combination of isoproterenol and IBMX is decreased by the absence of insulin. by Craig A. Eyster (9262632)

“…Scale bar 10μm. (B) Quantitation of mean fluorescence intensity (MFI) for PKA-substrate are presented as whisker plots that encompass data from at least 18 cells, as detailed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231806#pone.0231806.g001" target="_blank">Fig 1</a> (n = 3 biological replicates, and at least 6 cells per experiment). (*) Isoproterenol and IBMX treatment caused a significant increase (<i>p</i> < .001) compared to IBMX alone in all conditions. (‡) stimulated Akita and WT–ins conditions are significantly decreased compared to matching WT +ins conditions. …”

Decreased pH is necessary and sufficient for intestinal hyperinflammation. by M. Kristina Hamilton (9162785)

GIRK2^AgRP-KO mice show decreased EE associated with BAT dysfunction and decreased sympathetic activity. by Youjin Oh (3308670)

miR-450a decreases TMEM182 by directly targeting 3'-UTR. by En-Wei Hsing (154990)

The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size. by Sarah Fausett (11812818)

AMD CIDEC variants in the CIDE-N domain decrease dimerization affinity and all four variants decrease binding to effector partners PLIN1, AS160 and RAB8A. by Sehyun Kim (2697172)

Su(H) and RBPJ AOS variants decrease DNA binding. by Ellen K. Gagliani (11478756)

WT1 and LANA expression correlate with decreased T cell infiltrates. by Ayana E. Morales (17756335)

Pom-resistant PEL cells have decreased expression of cereblon. by Prabha Shrestha (776391)

Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

“…<p>A. Creation of tdT PUGKO mouse model with daily injections of progesterone from postnatal day 2–10 to knock down secretome factors was based on mouse model that results in infertility in female mice. …”

Impact of decreased PG synthesis on <i>A</i>. <i>tumefaciens</i>. by Michelle A. Williams (8446437)

STAT6-driven immunity decreases <i>N</i>. <i>brasiliensis</i> reproductive output and survival within host. by Annabel A. Ferguson (17616286)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Suppression of STAT6 consistently decreases WT_III encystment. by Joshua A. Kochanowsky (7543169)

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

Prey establishment and decrease in inter-population contacts protects T6SS sensitive lineages. by Marta Rudzite (15991136)

“…Mixed bacterial colonies of WT, Δ<i>rsmA</i>, Δ<i>retS</i>, and Δ<i>rsmA</i>Δ<i>rsmN</i> strains in different columns. …”

TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)